{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:22:23Z","timestamp":1791332543271,"version":"4.3.1"},"reference-count":26,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"DOI":"10.1210\/jc.2011-2229","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T05:33:16Z","timestamp":1323927196000},"page":"785-792","source":"Crossref","is-referenced-by-count":84,"title":["Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety"],"prefix":"10.1210","volume":"97","author":[{"given":"Vinaya","family":"Simha","sequence":"first","affiliation":[{"name":"Divisions of Nutrition and Metabolic Diseases (V.S., L.Su., C.Q., A.G.), Dallas, Texas 75390"},{"name":"Department of Internal Medicine and the Center for Human Nutrition (V.S., C.Q., A.G.), Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitha","family":"Subramanyam","sequence":"additional","affiliation":[{"name":"Divisions of Nutrition and Metabolic Diseases (V.S., L.Su., C.Q., A.G.), Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Szczepaniak","sequence":"additional","affiliation":[{"name":"Hypertension (L.Sz.), Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Quittner","sequence":"additional","affiliation":[{"name":"Divisions of Nutrition and Metabolic Diseases (V.S., L.Su., C.Q., A.G.), Dallas, Texas 75390"},{"name":"Department of Internal Medicine and the Center for Human Nutrition (V.S., C.Q., A.G.), Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Adams-Huet","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences (B.A.-H.), University of Texas Southwestern Medical Center, Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Snell","sequence":"additional","affiliation":[{"name":"Cardiology (P.S.), Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu","family":"Garg","sequence":"additional","affiliation":[{"name":"Divisions of Nutrition and Metabolic Diseases (V.S., L.Su., C.Q., A.G.), Dallas, Texas 75390"},{"name":"Department of Internal Medicine and the Center for Human Nutrition (V.S., C.Q., A.G.), Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113265920400_B1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy.","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113265920400_B2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diacare.26.1.30","article-title":"Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy.","volume":"26","author":"Simha","year":"2003","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113265920400_B3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113265920400_B4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.20672","article-title":"Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.","volume":"41","author":"Javor","year":"2005","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019041113265920400_B5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","article-title":"Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.","volume":"92","author":"Ebihara","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113265920400_B6","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1542\/peds.2006-3165","article-title":"Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy.","volume":"120","author":"Beltrand","year":"2007","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041113265920400_B7","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies.","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113265920400_B8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.metabol.2006.11.010","article-title":"Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy.","volume":"56","author":"Park","year":"2007","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113265920400_B9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ajcn\/74.3.295","article-title":"Leptin concentrations in the United States: relations with demographic and anthropometric measures.","volume":"74","author":"Ruhl","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t2019041113265920400_B10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1210\/jcem.87.2.8258","article-title":"Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia.","volume":"87","author":"Simha","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113265920400_B11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/13813450600736117","article-title":"The clinical efficacy of the adipocyte-derived hormone leptin in metabolic dysfunction.","volume":"112","author":"Gorden","year":"2006","journal-title":"Arch Physiol Biochem"},{"key":"key\n\t\t\t\t2019041113265920400_B12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications.","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113265920400_B13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","article-title":"Efficacy of leptin therapy in the different forms of human lipodystrophy.","volume":"53","author":"Chong","year":"2010","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113265920400_B14","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies.","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113265920400_B15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4158\/EP09154.RA","article-title":"Clinical classification and treatment of congenital and acquired lipodystrophy.","volume":"16","author":"Chan","year":"2010","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041113265920400_B16","first-page":"170","article-title":"Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety).","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113265920400_B17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/01.ATV.0000047460.27435.B8","article-title":"Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A\/C (LMNA) with partial lipodystrophy.","volume":"23","author":"Hegele","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019041113265920400_B18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.mol.0000217898.52197.18","article-title":"Lipodystrophy: lessons in lipid and energy metabolism.","volume":"17","author":"Simha","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"key\n\t\t\t\t2019041113265920400_B19","first-page":"1776","article-title":"Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety).","volume":"85","author":"Garg","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113265920400_B20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2265.2007.03095.x","article-title":"Leptin therapy for partial lipodystrophy linked to a PPAR-\u03b3 mutation.","volume":"68","author":"Guettier","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113265920400_B21","doi-asserted-by":"crossref","first-page":"980S","DOI":"10.3945\/ajcn.2008.26788C","article-title":"Leptin: a pivotal regulator of human energy homeostasis.","volume":"89","author":"Farooqi","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t2019041113265920400_B22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.metabol.2003.10.019","article-title":"Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy.","volume":"53","author":"Moran","year":"2004","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113265920400_B23","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1210\/jc.2003-031868","article-title":"Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency.","volume":"89","author":"McDuffie","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113265920400_B24","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1210\/jc.2003-032140","article-title":"Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy.","volume":"89","author":"Javor","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113265920400_B25","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1530\/EJE-09-1027","article-title":"Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin.","volume":"162","author":"Beltrand","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113265920400_B26","article-title":"Amylin and Takeda voluntarily suspend clinical activities in obesity trial","year":"2011"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/3\/785\/10415755\/jcem0785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T23:33:30Z","timestamp":1561073610000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/3\/785\/2536322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2011-2229","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}